Tessera Therapeutics, Inc. Looking for Research Associate I/II, NGS and Genomic Assays at Somerville, Massachusetts Full Time

Company Summary:

Tessera Therapeutics is pioneering Gene Writing™— a new biotechnology designed to offer scientists and clinicians the ability to write small and large therapeutic messages into the genome, thereby curing diseases at their source. Gene Writing holds the potential to become a new category in genetic medicine, building upon recent breakthroughs in gene therapy and gene editing while eliminating important limitations in their reach, utilization, and efficacy. Tessera Therapeutics was founded by Flagship Pioneering, a life sciences innovation enterprise that conceives, resources, and develops first-in-category companies to transform human health and sustainability.

Position Summary:

We are looking for an enthusiastic, detail-oriented, and highly motivated Research Associate/Senior Research Associate that can help advance our scientific mission. This person will join our NGS and Molecular Assays team and be responsible for running high throughput ScreenAmp and ddPCR assays to support our strategic scientific direction.

Key Responsibilities:

• Perform high throughput screening protocols to support data generation for the platform teams
• Troubleshoot basic library preparation issues and sequencing failures
• Run daily maintenance on miseq and Novaseq instruments
• Work with the automation team to implement validated automation protocols to the high throughput screening platform
• Work with a dynamic team and cross-train with other team members in the NGS core
• Maintain detailed electronic lab notebooks, and report QC results to team

Basic Qualifications:

• Those with a BSc degree in Molecular Biology, Genetics, Cell Biology or related field.
• Previous experience working in an NGS core sequencing facility is strongly preferred
• Prior experience with NGS library processing and Illumina/PacBio/nanopore instrumentation is preferred
• Attention to detail and ability to troubleshoot assay failures is strongly preferred
• Prior experience with the development and execution of automation for an NGS lab
• Detail-oriented with the ability to keep good experimental records
• Excellent communication skills, ability in working with highly skilled teams in a fast-paced environment

Preferred Qualifications, if you have these it would be a plus:

• • Experience with NGS assay qualification
  • Experience with high-throughput screening assays
  • Automation experience
  • Experience with gene editing or gene therapy

More About Flagship Pioneering

Flagship Pioneering has conceived of and created companies such as Moderna Therapeutics (NASDAQ: MRNA), Editas Medicine (NASDAQ: EDIT), Omega Therapeutics (NASDAQ: OMGA), Seres Therapeutics (NASDAQ: MCRB), and Indigo Agriculture. Since its launch in 2000, Flagship has applied its unique hypothesis-driven innovation process to originate and foster more than 100 scientific ventures. In 2021, Flagship Pioneering was ranked 12th globally on Fortune’s “Change the World” list, an annual ranking of companies that have made a positive social and environmental impact through activities that are part of their core business strategies.

Flagship Pioneering and our ecosystem companies are committed to equal employment opportunity regardless of race, color, ancestry, religion, sex, national origin, sexual orientation, age, citizenship, marital status, disability, gender identity or Veteran status.

Recruitment & Staffing Agencies: Flagship Pioneering and its affiliated Flagship Lab companies (collectively, “FSP”) do not accept unsolicited resumes from any source other than candidates. The submission of unsolicited resumes by recruitment or staffing agencies to FSP or its employees is strictly prohibited unless contacted directly by Flagship Pioneering’s internal Talent Acquisition team. Any resume submitted by an agency in the absence of a signed agreement will automatically become the property of FSP, and FSP will not owe any referral or other fees with respect thereto.